Investing
BioNTech stock get Buy rating from Canaccord, highlights pipeline focus
© Reuters.
On Thursday, Canaccord Genuity maintained its Buy rating and $171.00 price target for BioNTech (NASDAQ:), following the company’s financial results for the fourth quarter and full year of 2023. The firm’s analysis came after BioNTech’s stock saw an 8% decrease on the same day, which was attributed to the reported financial outcomes and future guidance slightly missing the mark.
BioNTech announced a full-year 2023 revenue of €3.8 billion, which was close to the previously forecasted €4 billion. However, the company revised its full-year 2024 guidance to a range of €2.5 billion to €3.1 billion, down from around €3 billion expected earlier. This adjustment has been perceived as a minor deviation from expectations and is thought to be a contributing factor to the day’s stock movement.
The investment firm highlighted the potential of BioNTech’s oncology pipeline, which is expected to have 10 assets in pivotal studies by the end of 2024 and aims to secure approvals for 10 oncology indications by 2030. With €17.7 billion in cash and security investments at the end of the year, BioNTech is well-positioned to support its clinical development through upcoming late-stage catalysts.
Canaccord Genuity’s analyst pointed out that the breadth of the oncology pipeline advancing collectively is more significant than individual pivotal readouts. The next updates from the pipeline are anticipated at the American Association for Cancer Research (AACR) conference, with programs focusing on pancreatic and non-small cell lung cancer (NSCLC), and further updates are expected at major medical conferences throughout the year.
The firm has updated its financial model to reflect the fourth quarter 2023 results and the revised guidance for 2024, adjusting its revenue estimate for 2024 to €3.1 billion from the previous €3.3 billion. Despite the adjustments, the firm’s price target remains unchanged, and it reiterates its positive stance on BioNTech’s stock.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here
12 Big Ideas From Business Books Published In 2024
3 Key Ways to Train Your Franchisees
Work Better from Anywhere with This Portable Touchscreen Monitor
Why Emotional Intelligence Is the Key to High-Impact Leadership
Spain stocks higher at close of trade; IBEX 35 up 0.33% By Investing.com
Kickstart Your Year With These Entrepreneurial Health Checkups
Expand Your Global Reach with Access to More Than 150 Languages for Life
KFC Announces Saucy, a Chicken Tenders-Focused Spinoff
This AI is the Key to Unlocking Explosive Sales Growth in 2025
Palantir, Anduril join forces with tech groups to bid for Pentagon contracts, FT reports By Reuters
Debt ceiling debate and its effect on the U.S. dollar
Debt ceiling default: Still no deal between parties
Stovall: If the U.S. defaults on its debt, all S&P 500 sectors will likely fall
What China's weaker-than-expected economy could mean for U.S. markets
A ‘Big Short’ investor sees financial disaster brewing in housing markets — again
-
Side Hustles6 days agoKickstart Your Year With These Entrepreneurial Health Checkups
-
Side Hustles5 days agoExpand Your Global Reach with Access to More Than 150 Languages for Life
-
Side Hustles4 days agoKFC Announces Saucy, a Chicken Tenders-Focused Spinoff
-
Side Hustles5 days agoThis AI is the Key to Unlocking Explosive Sales Growth in 2025
-
Investing4 days agoPalantir, Anduril join forces with tech groups to bid for Pentagon contracts, FT reports By Reuters
-
Side Hustles3 days ago4 Ways Content Can Make or Break the Customer Experience
-
Passive Income7 days ago5 Key Success Factors of Thriving Entrepreneurs
-
Passive Income6 days agoHow to Motivate, Inspire and Energize Your Employees